Opinion|Videos|June 6, 2024

Navigating Vitiligo Treatment: Decoding Pigmentation & Accessing Care

Rocco Serrao, MD, FAAD, addresses potential barriers to access and affordability of narrowband UVB phototherapy and topical medications for vitiligo treatment, while highlighting available resources to assist patients in overcoming these obstacles.

  1. How long would you treat this patient with this topical combination?
  2. How do you address any potential barriers to access or affordability associated with narrowband UVB phototherapy and topical medications, and what resources or support services are available to assist patients in overcoming these challenges?

Newsletter

Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.


Latest CME